No abstract available
Publication types
-
Clinical Trial, Phase III
-
Multicenter Study
-
Randomized Controlled Trial
MeSH terms
-
Aged
-
Anticoagulants / adverse effects
-
Anticoagulants / therapeutic use*
-
Atrial Fibrillation / complications
-
Atrial Fibrillation / diagnosis
-
Atrial Fibrillation / therapy*
-
Atrial Flutter / complications
-
Atrial Flutter / diagnosis
-
Atrial Flutter / therapy*
-
Combined Modality Therapy
-
Double-Blind Method
-
Electric Countershock* / adverse effects
-
Factor Xa Inhibitors / adverse effects
-
Factor Xa Inhibitors / therapeutic use*
-
Female
-
Hemorrhage / chemically induced
-
Humans
-
International Normalized Ratio
-
Male
-
Pyridines / adverse effects
-
Pyridines / therapeutic use*
-
Risk Factors
-
Stroke / diagnosis
-
Stroke / etiology
-
Stroke / prevention & control*
-
Thiazoles / adverse effects
-
Thiazoles / therapeutic use*
-
Time Factors
-
Treatment Outcome
-
Warfarin / adverse effects
-
Warfarin / therapeutic use*
Substances
-
Anticoagulants
-
Factor Xa Inhibitors
-
Pyridines
-
Thiazoles
-
Warfarin
-
edoxaban